RxDoctor Payments Data

Thomas Fehring, MD

Orthopaedic Surgery · Charlotte, NCNPI 1134101165

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $18,162,159 of the $18,323,415 with a category attached, or 99.1%. Depuy Synthes Products, Inc. accounts for 99.5% of it on its own, with 16 other manufacturers making up the rest. Among orthopaedic surgery clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$18,323,415in general payments, 2019–2025

Across 235 payments — averaging $77,972 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Depuy Synthes Products, Inc.$18.2M
  • Medical Device Business Services, Inc.$80K
  • Zimmer Biomet$419
  • Johnson & Johnson$347
  • Smith+Nephew$326
  • Stryker$201
  • plus $2K from 11 others

What the payments were for

  • Royalty or licence$18,162,15999%
  • Consulting fees$148,5401%
  • Travel & lodging$7,8060%
  • Food & beverage$4,9100%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$18,323,415 in reported general payments places this provider in the 95th percentile of 845 orthopaedic surgery providers in North Carolina.

See all orthopaedic surgery providers in North Carolina

Medicare billing

Part B allowed, 2024
$142,014
Medicare patients
191
Services billed
1,070

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Amoxicillin86$109
Meloxicam22$63
Clindamycin Hcl11$37

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Charlotte

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →